Literature DB >> 4616826

Current status of immunotherapy.

A Coates.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4616826     DOI： 10.2165/00003495-197408060-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  10 in total

Review 1.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

2.  Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.

Authors:  M Röllinghoff; B T Rouse; N L Warner
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

Review 3.  Implications of cancer immunity.

Authors:  F M Burnet
Journal:  Aust N Z J Med       Date:  1973-02

4.  Active immunotherapy with B.C.G. for recurrent malignant melanoma.

Authors:  J U Gutterman; G Mavligit; C McBride; E Frei; E J Freireich; E M Hersh
Journal:  Lancet       Date:  1973-06-02       Impact factor: 79.321

5.  Active immunotherapy for acute lymphoblastic leukaemia.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F De Vassal
Journal:  Lancet       Date:  1969-04-05       Impact factor: 79.321

Review 6.  Tumor-specific transplantation antigens: G. H. A. Clowes memorial lecture.

Authors:  G Klein
Journal:  Cancer Res       Date:  1968-04       Impact factor: 12.701

7.  Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Authors:  G Mathé; P Pouillart; F Lapeyraque
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

8.  Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer.

Authors:  G A Currie
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

9.  BCG immunotherapy of a rat sarcoma.

Authors:  R W Baldwin; M V Pimm
Journal:  Br J Cancer       Date:  1973-10       Impact factor: 7.640

10.  Immunotherapy for acute myelogenous leukaemia.

Authors:  R L Powles; D Crowther; C J Bateman; M E Beard; T J McElwain; J Russell; T A Lister; J M Whitehouse; P F Wrigley; M Pike; P Alexander; G H Fairley
Journal:  Br J Cancer       Date:  1973-11       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.